메뉴 건너뛰기




Volumn 9, Issue 7, 2003, Pages 277-278

Retroviral gene therapy - Where now?

Author keywords

[No Author keywords available]

Indexed keywords

RETROVIRUS VECTOR;

EID: 10744227175     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4914(03)00092-3     Document Type: Editorial
Times cited : (7)

References (10)
  • 1
    • 0028807727 scopus 로고
    • T lymphocyte-directed gene therapy for ADA-SCID: Initial trial results after 4 years
    • Blaese, R.M. et al. (1995) T lymphocyte-directed gene therapy for ADA-SCID: initial trial results after 4 years. Science 270, 475-480
    • (1995) Science , vol.270 , pp. 475-480
    • Blaese, R.M.1
  • 2
    • 0034724857 scopus 로고    scopus 로고
    • Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease
    • Cavazzana-Calvo, M. et al. (2000) Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288, 669-672
    • (2000) Science , vol.288 , pp. 669-672
    • Cavazzana-Calvo, M.1
  • 3
    • 0037129435 scopus 로고    scopus 로고
    • Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy
    • Hacein-Bey-Abina, S. et al. (2002) Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N. Engl. J. Med. 346, 1185-1193
    • (2002) N. Engl. J. Med. , vol.346 , pp. 1185-1193
    • Hacein-Bey-Abina, S.1
  • 4
    • 0037189401 scopus 로고    scopus 로고
    • Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning
    • Aiuti, A. et al. (2002) Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science 296, 2410-2413
    • (2002) Science , vol.296 , pp. 2410-2413
    • Aiuti, A.1
  • 5
    • 0037448352 scopus 로고    scopus 로고
    • A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency
    • Hacein-Bey-Abina, S. et al. (2003) A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N. Engl. J. Med. 348, 255-256
    • (2003) N. Engl. J. Med. , vol.348 , pp. 255-256
    • Hacein-Bey-Abina, S.1
  • 6
    • 0027762220 scopus 로고
    • LIM domain proteins in leukaemia and development
    • Sanchez-Garcia, I. and Rabbitts, T.H. (1993) LIM domain proteins in leukaemia and development. Semin. Cancer Biol. 4, 349-358
    • (1993) Semin. Cancer Biol. , vol.4 , pp. 349-358
    • Sanchez-Garcia, I.1    Rabbitts, T.H.2
  • 7
    • 0037443457 scopus 로고    scopus 로고
    • Side effects of retroviral gene transfer into hematopoietic stem cells
    • Baum, C. et al. (2003) Side effects of retroviral gene transfer into hematopoietic stem cells. Blood 101, 2099-2114
    • (2003) Blood , vol.101 , pp. 2099-2114
    • Baum, C.1
  • 8
    • 0036561908 scopus 로고    scopus 로고
    • Modelling the molecular circuitry of cancer
    • Hahn, W.C. and Weinberg, R.A. (2002) Modelling the molecular circuitry of cancer. Nat. Rev. Cancer 2, 331-341
    • (2002) Nat. Rev. Cancer , vol.2 , pp. 331-341
    • Hahn, W.C.1    Weinberg, R.A.2
  • 9
    • 0034776511 scopus 로고    scopus 로고
    • Recent advances in retrovirus vector-mediated gene therapy: Teaching an old vector new tricks
    • Weber, E. et al. (2001) Recent advances in retrovirus vector-mediated gene therapy: teaching an old vector new tricks. Curr. Opin. Mol. Ther. 3,439-453
    • (2001) Curr. Opin. Mol. Ther. , vol.3 , pp. 439-453
    • Weber, E.1
  • 10
    • 0036518340 scopus 로고    scopus 로고
    • Encapsulated cells producing retroviral vectors for in vivo gene transfer
    • Saller, R.M. et al. (2002) Encapsulated cells producing retroviral vectors for in vivo gene transfer. J. Gene Med. 4, 150-160
    • (2002) J. Gene Med. , vol.4 , pp. 150-160
    • Saller, R.M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.